The relative increase of heart work caused by aminorex in dogs is greater in the right ventricle than in the left. In contrast, noradrenalin, amphetamine, ephedrine and tyramine are more effective in the left ventricle. In contrast to sympathomimetics, aminorex increased the pulmonary vascular resistance more than the total peripheral resistance. This confirms that aminorex acts preferentially on the pulmonary circulation. None of the following substances can block the effect of aminorex on the pulmonary pressure of dogs: phentolamine, methysergide, promethazine, and a combination of phentolamine with methysergide or promethazine. As opposed to this, the increase in pulmonary pressure induced by noradrenalin, adrenalin, tyramine, 5-hydroxytryptamine or histamine can be blocked by phentolamine, methysergide, or promethazine. Phentolamine prevents the effect of aminorex on the pulmonary vascular resistance. The increase in the pulmonary artery pressure is caused by an increase in the cardiac output. Aminorex also acts preferentially on the pulmonary circulation of cats. This action is a peripheral one, because it is the same in spinal cats. Our experiments clearly show that the effect of aminorex on pulmonary circulation is not a sympathomimetic effect.

Keywords:
Aminorex, Antagonists, Histamine, 5-Hydroxytryptamine, Pulmonary circulation, Sympathomimetic amines
This content is only available via PDF.
© 1973 S. Karger AG, Basel
1973
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.